Pharmacodynamic Profiles of Ticagrelor in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Different Loading Dosage Regimens
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2015
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Myocardial infarction; Pulmonary embolism; Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 17 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.